Cargando…
Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1
Spongistatin 1 is among the most potent anti-proliferative agents ever discovered rendering it an attractive candidate for development as a payload for antibody–drug conjugates and other targeted delivery approaches. Unfortunately, it is unavailable from natural sources and its size and complex ster...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226463/ https://www.ncbi.nlm.nih.gov/pubmed/30413713 http://dx.doi.org/10.1038/s41467-018-07259-x |
_version_ | 1783369946737147904 |
---|---|
author | Suen, Linda M. Tekle-Smith, Makeda A. Williamson, Kevin S. Infantine, Joshua R. Reznik, Samuel K. Tanis, Paul S. Casselman, Tyler D. Sackett, Dan L. Leighton, James L. |
author_facet | Suen, Linda M. Tekle-Smith, Makeda A. Williamson, Kevin S. Infantine, Joshua R. Reznik, Samuel K. Tanis, Paul S. Casselman, Tyler D. Sackett, Dan L. Leighton, James L. |
author_sort | Suen, Linda M. |
collection | PubMed |
description | Spongistatin 1 is among the most potent anti-proliferative agents ever discovered rendering it an attractive candidate for development as a payload for antibody–drug conjugates and other targeted delivery approaches. Unfortunately, it is unavailable from natural sources and its size and complex stereostructure render chemical synthesis highly time- and resource-intensive. As a result, the design and synthesis of more acid-stable and linker functional group-equipped analogs that retain the low picomolar potency of the parent natural product requires more efficient and step-economical synthetic access. Using uniquely enabling direct complex fragment coupling crotyl- and alkallylsilylation reactions, we report a 22-step synthesis of a rationally designed D-ring modified analog of spongistatin 1 that is characterized by GI(50) values in the low picomolar range, and a proof-of-concept result that the C(15) acetate may be replaced with linker functional group-bearing esters with only minimal reductions in potency. |
format | Online Article Text |
id | pubmed-6226463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62264632018-11-13 Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 Suen, Linda M. Tekle-Smith, Makeda A. Williamson, Kevin S. Infantine, Joshua R. Reznik, Samuel K. Tanis, Paul S. Casselman, Tyler D. Sackett, Dan L. Leighton, James L. Nat Commun Article Spongistatin 1 is among the most potent anti-proliferative agents ever discovered rendering it an attractive candidate for development as a payload for antibody–drug conjugates and other targeted delivery approaches. Unfortunately, it is unavailable from natural sources and its size and complex stereostructure render chemical synthesis highly time- and resource-intensive. As a result, the design and synthesis of more acid-stable and linker functional group-equipped analogs that retain the low picomolar potency of the parent natural product requires more efficient and step-economical synthetic access. Using uniquely enabling direct complex fragment coupling crotyl- and alkallylsilylation reactions, we report a 22-step synthesis of a rationally designed D-ring modified analog of spongistatin 1 that is characterized by GI(50) values in the low picomolar range, and a proof-of-concept result that the C(15) acetate may be replaced with linker functional group-bearing esters with only minimal reductions in potency. Nature Publishing Group UK 2018-11-09 /pmc/articles/PMC6226463/ /pubmed/30413713 http://dx.doi.org/10.1038/s41467-018-07259-x Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Suen, Linda M. Tekle-Smith, Makeda A. Williamson, Kevin S. Infantine, Joshua R. Reznik, Samuel K. Tanis, Paul S. Casselman, Tyler D. Sackett, Dan L. Leighton, James L. Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 |
title | Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 |
title_full | Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 |
title_fullStr | Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 |
title_full_unstemmed | Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 |
title_short | Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1 |
title_sort | design and 22-step synthesis of highly potent d-ring modified and linker-equipped analogs of spongistatin 1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226463/ https://www.ncbi.nlm.nih.gov/pubmed/30413713 http://dx.doi.org/10.1038/s41467-018-07259-x |
work_keys_str_mv | AT suenlindam designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT teklesmithmakedaa designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT williamsonkevins designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT infantinejoshuar designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT rezniksamuelk designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT tanispauls designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT casselmantylerd designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT sackettdanl designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 AT leightonjamesl designand22stepsynthesisofhighlypotentdringmodifiedandlinkerequippedanalogsofspongistatin1 |